Sfoglia per Relatore
Mostrati risultati da 1 a 8 di 8
A Comparative drug-response analysis of KRAS4A and 4B splicing isoforms in KRAS-mutant Lung Adenocarcinoma.
2023/2024 RICCIATO, MIRCO
Generation and characterization of PROTAC strategy as a new anticancer therapy
2021/2022 PETRINI, ETTORE
Inibizione dell'autofagia nel trattamento del tumore al pancreas
2020/2021 GARAU, EMANUEL
Mechanisms of resistance to KRAS G12C inhibitors in lung cancer
2023/2024 SICCARDI, RAFFAELE
New combination therapies for the treatment of KRAS-driven tumors: the interplay between aneuploidy and MAPK signaling
2023/2024 BERARDELLI, EMILIA
Oncogenic mutant KRAS inhibition through oxidation at Cysteine 118
2023/2024 PETRINI, ETTORE
Ras Isoforms in Lung Cancer and New Target Therapies Development
2023/2024 PERANO, ALESSANDRO
The Local Microbiota as an Emerging Feature of the Tumor Microenvironment
2022/2023 MIGNACCO, ROBERTO
Mostrati risultati da 1 a 8 di 8
Legenda icone
- file disponibili solo agli amministratori
- nessun file disponibile